Nexalin Technology, Inc. - NXL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | CEO | A | A | 1,000,000.0 | 0.0 | 0.0 | 2,387,024.0 | View | |
| Dec 23, 2025 | CFO | A | A | 100,000.0 | 0.0 | 0.0 | 230,435.0 | View | |
| Dec 23, 2025 | Chief Medical Officer | A | A | 1,000,000.0 | 0.0 | 0.0 | 2,484,809.0 | View | |
| Dec 23, 2025 | Sr. VP - Quality - Regulatory | A | A | 100,000.0 | 0.0 | 0.0 | 210,620.0 | View | |
| Dec 23, 2025 | — | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Dec 23, 2025 | — | A | A | 100,000.0 | 0.0 | 0.0 | 362,500.0 | View |